US Broker Ratings

Tyra Biosciences, Inc. (TYRA) Stock Analysis: Biotechnology Innovator with a Remarkable 194% Upside Potential

Tyra Biosciences, Inc. (NASDAQ: TYRA), a clinical-stage biotechnology company, is drawing significant attention from investors with its innovative approach to precision medicine and a striking potential..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Navigating a 38% Potential Upside with Strategic Diagnostics

For investors eyeing opportunities in the healthcare sector, Myriad Genetics, Inc. (NASDAQ: MYGN) presents a compelling case with its molecular diagnostic offerings. Despite facing challenges, the..

CorMedix Inc. (CRMD): Investor Outlook Reveals a Promising 62% Potential Upside

CorMedix Inc. (NASDAQ: CRMD), a key player in the biotechnology sector, is garnering attention from investors with an impressive potential upside of 62.25%. This biopharmaceutical company,..

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: 231% Potential Upside Beckons Investors

Trevi Therapeutics, Inc. (NASDAQ: TRVI) is capturing significant attention in the biotechnology sector, thanks to its impressive potential upside of 231%. This clinical-stage biopharmaceutical company is..

SIGA Technologies Inc. (SIGA) Stock Analysis: Unpacking the Forward P/E of 4.08 in a Volatile Healthcare Market

SIGA Technologies Inc. (NASDAQ: SIGA), a leading player in the health security market with a focus on antiviral treatments, presents a unique proposition for investors, particularly..

iRadimed Corporation (IRMD) Stock Analysis: Exploring a 19% Upside Potential in the Healthcare Sector

iRadimed Corporation (NASDAQ: IRMD), a leading player in the healthcare sector, has been making waves with its innovative medical devices that cater specifically to the magnetic..

Immunome, Inc. (IMNM)

⚠️ No article content returned.

..

Tectonic Therapeutic, Inc. (TECX): Investor Outlook with a Staggering 279% Potential Upside

Tectonic Therapeutic, Inc. (NASDAQ: TECX), a promising player in the biotechnology sector, is capturing attention with a potential upside of 279.07%, according to analysts. Specializing in..

Septerna, Inc. (SEPN) Stock Analysis: Exploring the 107.62% Potential Upside in Biotechnology

Septerna, Inc. (NASDAQ: SEPN), a promising player in the biotechnology sector, stands at the intersection of innovation and opportunity, with a striking potential upside of 107.62%..

Castle Biosciences, Inc. (CSTL) Investor Outlook: Analyzing a Potential 80.89% Upside

Castle Biosciences, Inc. (NASDAQ: CSTL) emerges as a compelling opportunity within the healthcare sector, specifically in the diagnostics and research industry. Headquartered in Friendswood, Texas, this..

Xeris Biopharma Holdings (XERS): Investor Outlook Amid Strong Revenue Growth and Promising Analyst Ratings

Xeris Biopharma Holdings, Inc. (XERS) is a company that is capturing the attention of investors within the biotechnology sector due to its impressive revenue growth and..

Semler Scientific, Inc. (SMLR) Stock Analysis: Navigating Revenue Challenges with Strong Cash Flow

Semler Scientific, Inc. (NASDAQ: SMLR), a notable player in the healthcare sector specializing in medical devices, is currently facing a complex financial landscape. Headquartered in Santa..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Exploring a 29.81% Potential Upside in the Biotech Sector

Fortrea Holdings Inc. (NASDAQ: FTRE) presents a compelling opportunity for investors intrigued by the biotechnology sector. As a contract research organization, Fortrea offers a comprehensive suite..

Immatics N.V. (IMTX): Investor Outlook with a Potential 138.89% Upside

Immatics N.V. (NASDAQ: IMTX) is gaining attention in the healthcare sector with its innovative approach to cancer treatment through T cell redirecting immunotherapies. This biotechnology company,..

Arvinas, Inc. (ARVN) Stock Analysis: A Potential 145% Upside in the Biotech Sector

For investors seeking opportunities in the healthcare sector, particularly in biotechnology, Arvinas, Inc. (NASDAQ: ARVN) presents an intriguing prospect. This clinical-stage company is pioneering in the..

Vir Biotechnology (VIR) Stock Analysis: Potential 201% Upside Amid Analyst Optimism

Investors with a keen eye on the biotechnology sector may want to consider the intriguing case of Vir Biotechnology, Inc. (VIR), a company that has recently..

Claritev Corporation (CTEV) Stock Analysis: Navigating a Healthcare Data Giant with a 67.53 RSI

Claritev Corporation (CTEV), a notable player in the healthcare sector, operates at the intersection of data analytics and technology-enabled cost management. Specializing in health information services,..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: Analyst Ratings Point to Significant 29.89% Upside

Investors with a keen eye on the biotechnology sector may find LENZ Therapeutics, Inc. (NASDAQ: LENZ) an intriguing opportunity. As a biopharmaceutical company dedicated to the..

Cogent Biosciences (COGT) Stock Analysis: Exploring a 49% Potential Upside in the Biotech Sector

Cogent Biosciences, Inc. (NASDAQ: COGT) is gaining traction among investors with a compelling narrative in the biotechnology sector. With a market capitalization of $1.58 billion, this..

Pharvaris N.V. (PHVS) Stock Analysis: A Biotech with 72.83% Potential Upside and Strong Buy Ratings

Pharvaris N.V. (NASDAQ: PHVS), a dynamic player in the biotechnology sector, is making notable waves in the healthcare industry. This Swiss-based company, specializing in the development..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds